Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation

KR Reddy, S Mutalik, S Reddy - AAPS pharmscitech, 2003 - Springer
The objective of the present study was to develop once-daily sustained-release matrix
tablets of nicorandil, a novel potassium channel opener used in cardiovascular diseases …
被引用次数：493 相关文章

Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation

KR Reddy, S Mutalik, S Reddy - AAPS PharmSciTech, 2003 - pubmed.ncbi.nlm.nih.gov
The objective of the present study was to develop once-daily sustained-release matrix
tablets of nicorandil, a novel potassium channel opener used in cardiovascular diseases …

Once-daily sustained-release matrix tablets of nicorandil: Formulation and in vitro evaluation

KR Reddy, S Mutalik, S Reddy - AAPS PharmSciTech, 2003 - infona.pl
The objective of the present study was to develop once-daily sustained-release matrix
tablets of nicorandil, a novel potassium channel opener used in cardiovascular diseases …

[引用][C] Once-daily sustained-release matrix tablets of nicorandil: Formulation and in vitro evaluation

KR Reddy, S Mutalik, S Reddy - AAPS PharmSciTech, 2003 - cir.nii.ac.jp
Once-daily sustained-release matrix tablets of nicorandil: Formulation and in vitro
evaluation | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
[PDF] academia.edu

[PDF][PDF] Once-Daily Sustained-Release Matrix Tablets of Nicorandil: Formulation and In Vitro Evaluation

KR Reddy, S Mutalik, S Reddy - academia.edu
The objective of the present study was to develop once-daily sustained-release matrix
tablets of nicorandil, a novel potassium channel opener used in cardiovascular diseases …
[PDF] researchgate.net

[PDF][PDF] Once-Daily Sustained-Release Matrix Tablets of Nicorandil: Formulation and In Vitro Evaluation

KR Reddy, S Mutalik, S Reddy - researchgate.net
The objective of the present study was to develop once-daily sustained-release matrix
tablets of nicorandil, a novel potassium channel opener used in cardiovascular diseases …

Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation.

KR Reddy, S Mutalik, S Reddy - AAPS Pharmscitech, 2003 - europepmc.org
The objective of the present study was to develop once-daily sustained-release matrix
tablets of nicorandil, a novel potassium channel opener used in cardiovascular diseases …

Once-daily sustained-release matrix tablets of nicorandil: Formulation and in vitro evaluation.

K Reddy, S Mutalik, S Reddy - AAPS PharmSciTech, 2003 - search.ebscohost.com
The objective of the present study was to develop once-daily sustained-release matrix
tablets of nicorandil, a novel potassium channel opener used in cardiovascular diseases …

Once-daily sustained-release matrix tablets of nicorandil: Formulation and in vitro evaluation

KR Reddy, S Mutalik, S Reddy - AAPS PharmSciTech, 2003 - ncbi.nlm.nih.gov
The objective of the present study was to develop once-daily sustained-release matrix
tablets of nicorandil, a novel potassium channel opener used in cardiovascular diseases …
[PDF] academia.edu

[PDF][PDF] Once-Daily Sustained-Release Matrix Tablets of Nicorandil: Formulation and In Vitro Evaluation

KR Reddy, S Mutalik, S Reddy - academia.edu
The objective of the present study was to develop once-daily sustained-release matrix
tablets of nicorandil, a novel potassium channel opener used in cardiovascular diseases …